Tight Junction in Blood‐Brain Barrier: An Overview of Structure, Regulation, and Regulator Substances
Open accessThe DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Abstract
SUMMARY: Blood‐brain barrier (BBB) is a dynamic interference that regulates the nutrition and toxic substance in and out of the central nervous system (CNS), and plays a crucial role in maintaining a stable circumstance of the CNS. Tight junctions among adjacent cells form the basic structure of BBB to limiting paracellular permeability. In the present review, the constituents of tight junction proteins are depicted in detail, together with the regulation of tight junction under stimulation and in pathological conditions. Tight junction modulators are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,261
Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917 · cited 1×
“found that BBB is permeable to molecules with molecular mass at <800 Da in claudin-5 deficient mice [21].”
BackgroundEndothelial Cell-to-Cell Junctions: Molecular Organization and Role in Vascular Homeostasis
Bazzoni, G., & Dejana, E. (2004) · Physiological Reviews · doi:10.1152/physrev.00035.2003 · Cited by 1,389
Complex Phenotype of Mice Lacking Occludin, a Component of Tight Junction Strands
Saitou, M., Furuse, M., Sasaki, H., Schulzke, J.-D., Fromm, M., Takano, H., Noda, T., & Tsukita, S. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.12.4131 · Cited by 1,195 · cited 2×
“Occludin-deficient mice exhibit complex gross and histological phenotypes, including calcification in the brain, showing the functions of occludin are more complex than just a building block in endothelial cells and other tissues [14].”
BackgroundPardridge, W. M. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.013 · Cited by 1,191
González-Mariscal, L., Betanzos, A., Nava, P., & Jaramillo, B. E. (2003) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(02)00037-8 · Cited by 1,160
Yang, Y., Estrada, E. Y., Thompson, J. F., Liu, W., & Rosenberg, G. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600375 · Cited by 1,060
Self-citationBlood-brain barrier tight junction permeability and ischemic stroke
Sandoval, K. E., & Witt, K. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.005 · Cited by 964
Tight Junction Pore and Leak Pathways: A Dynamic Duo
Shen, L., Weber, C. R., Raleigh, D. R., Yu, D., & Turner, J. R. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142150 · Cited by 872
Umeda, K., Ikenouchi, J., Katahira-Tayama, S., Furuse, K., Sasaki, H., Nakayama, M., Matsui, T., Tsukita, S., Furuse, M., & Tsukita, S. (2006) · Cell · doi:10.1016/j.cell.2006.06.043 · Cited by 823
Molecular physiology and pathophysiology of tight junctions in the blood–brain barrier
Huber, J. D., Egleton, R. D., & Davis, T. P. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02004-x · Cited by 786
Modelling of the blood–brain barrier in drug discovery and development
Cecchelli, R., Berezowski, V., Lundquist, S., Culot, M., Renftel, M., Dehouck, M.-P., & Fenart, L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2368 · Cited by 618
Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches
Cardoso, F. L., Brites, D., & Brito, M. A. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.05.003 · Cited by 569
Tight Junctions of the Blood–Brain Barrier
Kniesel, U., & Wolburg, H. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006995910836 · Cited by 519
The role of junctional adhesion molecules in vascular inflammation
Weber, C., Fraemohs, L., & Dejana, E. (2007) · Nature Reviews Immunology · doi:10.1038/nri2096 · Cited by 503
Sheikov, N., McDannold, N., Sharma, S., & Hynynen, K. (2008) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2007.12.015 · Cited by 493
Occludin: Structure, function and regulation
FELDMAN, G., MULLIN, J., & RYAN, M. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.01.009 · Cited by 485
The Role of Tau in Alzheimer's Disease and Related Disorders
Medeiros, R., Baglietto‐Vargas, D., & LaFerla, F. M. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00177.x · Cited by 432
Deli, M. A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.09.016 · Cited by 385
Kirk, J., Plumb, J., Mirakhur, M., & McQuaid, S. (2003) · The Journal of Pathology · doi:10.1002/path.1434 · Cited by 375
Junctional complexes of the blood–brain barrier: permeability changes in neuroinflammation
Petty, M. A., & Lo, E. H. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00128-4 · Cited by 360
Tight junction modulation and its relationship to drug delivery
SALAMA, N., EDDINGTON, N., & FASANO, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.01.003 · Cited by 357
Neurodegenerative disorders associated with diabetes mellitus
Ristow, M. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0552-1 · Cited by 352
Hawkins, B. T., Lundeen, T. F., Norwood, K. M., Brooks, H. L., & Egleton, R. D. (2006) · Diabetologia · doi:10.1007/s00125-006-0485-z · Cited by 346
Blood–Brain Barrier Pathology in Alzheimer's and Parkinson's Disease: Implications for Drug Therapy
Desai, B. S., Monahan, A. J., Carvey, P. M., & Hendey, B. (2007) · Cell Transplantation · doi:10.3727/000000007783464731 · Cited by 339 · cited 1×
“In vitro experiments demonstrated that amyloid-β deposition downregulates the mRNA and protein level of ZO-1 and occludin, and disturbs organization of claudin-5, suggesting that AD affects the function of BBB by altering the expression and location of TJ proteins [42].”
BackgroundKanoski, S. E., Zhang, Y., Zheng, W., & Davidson, T. L. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091414 · Cited by 324
Mechanisms of Disease: The Blood-Brain Barrier
Neuwelt, E. A. (2004) · Neurosurgery · doi:10.1227/01.neu.0000097715.11966.8e · Cited by 314
Förster, C., Burek, M., Romero, I. A., Weksler, B., Couraud, P., & Drenckhahn, D. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.146852 · Cited by 307
Chen, L., Yokel, R. A., Hennig, B., & Toborek, M. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9131-5 · Cited by 293
Establishment and Characterization of Cultured Epithelial Cells Lacking Expression of ZO-1
Umeda, K., Matsui, T., Nakayama, M., Furuse, K., Sasaki, H., Furuse, M., & Tsukita, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406563200 · Cited by 263
The Dual Role of Zonula Occludens (ZO) Proteins
Bauer, H., Zweimueller-Mayer, J., Steinbacher, P., Lametschwandtner, A., & Bauer, H. C. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/402593 · Cited by 244
Koto, T., Takubo, K., Ishida, S., Shinoda, H., Inoue, M., Tsubota, K., Okada, Y., & Ikeda, E. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060693 · Cited by 239
Stoll, G., Kleinschnitz, C., & Nieswandt, B. (2008) · Blood · doi:10.1182/blood-2008-04-144758 · Cited by 237
MANDELL, K., & PARKOS, C. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.01.005 · Cited by 231
Mechanisms of the Blood–Brain Barrier Disruption in HIV-1 Infection
Toborek, M., Lee, Y. W., Flora, G., Pu, H., András, I. E., Wylegala, E., Hennig, B., & Nath, A. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-1383-x · Cited by 228
Förster, C., Silwedel, C., Golenhofen, N., Burek, M., Kietz, S., Mankertz, J., & Drenckhahn, D. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.084038 · Cited by 214
Ramirez, S. H., Potula, R., Fan, S., Eidem, T., Papugani, A., Reichenbach, N., Dykstra, H., Weksler, B. B., Romero, I. A., Couraud, P. O., et al. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.112 · Cited by 208
Huber, J. D., VanGilder, R. L., & Houser, K. A. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00489.2006 · Cited by 205
Persidsky, Y., Heilman, D., Haorah, J., Zelivyanskaya, M., Persidsky, R., Weber, G. A., Shimokawa, H., Kaibuchi, K., & Ikezu, T. (2006) · Blood · doi:10.1182/blood-2005-11-4721 · Cited by 200
Connecting Vascular and Nervous System Development: Angiogenesis and the Blood-Brain Barrier
Tam, S. J., & Watts, R. J. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-152829 · Cited by 197 · cited 2×
“The blood-brain barrier (BBB) regulates the flow of essential components into and out of the central nervous system (CNS) and minimizes the influence of toxic compounds and pathogens to the CNS [1,2].”
BackgroundXu, J., Kausalya, P. J., Phua, D. C. Y., Ali, S. M., Hossain, Z., & Hunziker, W. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00891-07 · Cited by 197
Liu, W., Hendren, J., Qin, X., Shen, J., & Liu, K. J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05821.x · Cited by 194
Self-citationBlood–brain barrier permeability in Alzheimer's disease: a case–control MRI study
Starr, J. M., Farrall, A. J., Armitage, P., McGurn, B., & Wardlaw, J. (2009) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2008.04.003 · Cited by 189
András, I. E., Pu, H., Deli, M. A., Nath, A., Hennig, B., & Toborek, M. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10762 · Cited by 189
Vos, C. M. P., Geurts, J. J. G., Montagne, L., van Haastert, E. S., Bö, L., van der Valk, P., Barkhof, F., & de Vries, H. E. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.06.012 · Cited by 188
Nakajima, A., Inoue, E., Tanaka, E., Singh, G., Sato, E., Hoshi, D., Shidara, K., Hara, M., Momohara, S., Taniguchi, A., et al. (2010) · Scandinavian Journal of Rheumatology · doi:10.3109/03009741003604542 · Cited by 167
Chaudhuri, A., Yang, B. Y., Gendelman, H. E., Persidsky, Y., & Kanmogne, G. D. (2007) · Blood · doi:10.1182/blood-2007-05-091207 · Cited by 155
Brooks, T. A., Hawkins, B. T., Huber, J. D., Egleton, R. D., & Davis, T. P. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01288.2004 · Cited by 154
Bake, S., & Sohrabji, F. (2004) · Endocrinology · doi:10.1210/en.2004-0984 · Cited by 152
Martins, T., Baptista, S., Gonçalves, J., Leal, E. C., Milhazes, N., Borges, F., Ribeiro, C., Quintela, O., Lendoiro, E., López‐Rivadulla, M., et al. (2011) · Brain Research · doi:10.1016/j.brainres.2011.07.013 · Cited by 146
From Hypertension to Stroke: Mechanisms and Potential Prevention Strategies
Yu, J., Rui-rui, Z. H. O. U., & Cai, G. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00264.x · Cited by 145
MMP-Mediated Disruption of Claudin-5 in the Blood–Brain Barrier of Rat Brain After Cerebral Ischemia
Yang, Y., & Rosenberg, G. A. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61779-185-7_24 · Cited by 144
Molecular Anatomy of the Brain Endothelial Barrier: An Overview of the Distributional Features
Ueno, M. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707780597943 · Cited by 139
Mahajan, S. D., Aalinkeel, R., Sykes, D. E., Reynolds, J. L., Bindukumar, B., Adal, A., Qi, M., Toh, J., Xu, G., Prasad, P. N., et al. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.093 · Cited by 138
Caraci, F., Battaglia, G., Bruno, V., Bosco, P., Carbonaro, V., Giuffrida, M. L., Drago, F., Sortino, M. A., Nicoletti, F., & Copani, A. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00115.x · Cited by 135
András, I. E., Pu, H., Tian, J., Deli, M. A., Nath, A., Hennig, B., & Toborek, M. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600115 · Cited by 121
Multiple forms of estrogen receptor-α in cerebral blood vessels: regulation by estrogen
Stirone, C., Duckles, S. P., & Krause, D. N. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00165.2002 · Cited by 121
Colgan, O. C., Ferguson, G., Collins, N. T., Murphy, R. P., Meade, G., Cahill, P. A., & Cummins, P. M. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01177.2006 · Cited by 121
Sharma, H. S., & Kiyatkin, E. A. (2009) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2008.08.002 · Cited by 118
Molecular complexity of vertebrate tight junctions (Review)
D'Atri, F., & Citi, S. (2002) · Molecular Membrane Biology · doi:10.1080/09687680210129236 · Cited by 116
Zhang, J., Piontek, J., Wolburg, H., Piehl, C., Liss, M., Otten, C., Christ, A., Willnow, T. E., Blasig, I. E., & Abdelilah‐Seyfried, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911996107 · Cited by 115
Diabetes, Cognitive Function, and the Blood-Brain Barrier
Huber, J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784705441 · Cited by 115
Willis, C. L., Meske, D. S., & Davis, T. P. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.119 · Cited by 112
JAM Family and Related Proteins in Leukocyte Migration (Vestweber Series)
Bradfield, P. F., Nourshargh, S., Aurrand-Lions, M., & Imhof, B. A. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.147694 · Cited by 111
Tight Junction Regulation by Morphine and HIV-1 Tat Modulates Blood–Brain Barrier Permeability
Mahajan, S. D., Aalinkeel, R., Sykes, D. E., Reynolds, J. L., Bindukumar, B., Fernandez, S. F., Chawda, R., Shanahan, T., & Schwartz, S. A. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9208-1 · Cited by 109
Huang, W., Eum, S. Y., András, I. E., Hennig, B., & Toborek, M. (2009) · The FASEB Journal · doi:10.1096/fj.08-121624 · Cited by 108
Yao, H., Duan, M., & Buch, S. (2011) · Blood · doi:10.1182/blood-2010-10-313593 · Cited by 104
Cingulin interacts with F‐actin in vitro
D’Atri, F., & Citi, S. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02936-2 · Cited by 104
Satoh, H., Zhong, Y., Isomura, H., Saitoh, M., Enomoto, K., Sawada, N., & Mori, M. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0034 · Cited by 104
Disruption of the cingulin gene does not prevent tight junction formation but alters gene expression
Guillemot, L., Hammar, E., Kaister, C., Ritz, J., Caille, D., Jond, L., Bauer, C., Meda, P., & Citi, S. (2004) · Journal of Cell Science · doi:10.1242/jcs.01399 · Cited by 91
Adrenomedullin Improves the Blood–Brain Barrier Function Through the Expression of Claudin-5
Honda, M., Nakagawa, S., Hayashi, K., Kitagawa, N., Tsutsumi, K., Nagata, I., & Niwa, M. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9028-x · Cited by 87
The integrity of the blood?brain barrier in Alzheimer?s disease
Algotsson, A., & Winblad, B. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00823.x · Cited by 86
Expression and distribution of ZO‐3, a tight junction MAGUK protein, in mouse tissues
Inoko, A., Itoh, M., Tamura, A., Matsuda, M., Furuse, M., & Tsukita, S. (2003) · Genes to Cells · doi:10.1046/j.1365-2443.2003.00681.x · Cited by 82
Challenges for blood–brain barrier (BBB) screening
Jeffrey, P., & Summerfield, S. G. (2007) · Xenobiotica · doi:10.1080/00498250701570285 · Cited by 79
Bake, S., Friedman, J. A., & Sohrabji, F. (2009) · Microvascular Research · doi:10.1016/j.mvr.2009.06.009 · Cited by 77
Imaging the future of stroke: I. Ischemia
Liebeskind, D. S. (2009) · Annals of Neurology · doi:10.1002/ana.21787 · Cited by 76
Dhillon, N. K., Peng, F., Bokhari, S. M., Callen, S. E., Shin, S., Zhu, X., Kim, K.-J., & Buch, S. J. (2007) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9091-1 · Cited by 75
Tight Junction Proteins as Channel Formers and Barrier Builders
Amasheh, S., Milatz, S., Krug, S. M., Markov, A. G., Günzel, D., Amasheh, M., & Fromm, M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04439.x · Cited by 75
Cheng, Z., Zhang, J., Liu, H., Li, Y., Zhao, Y., & Yang, E. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.033324 · Cited by 73
Helms, H. C. C., Waagepetersen, H. S., Nielsen, C. U., & Brodin, B. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9237-6 · Cited by 73
McCaffrey, G., Seelbach, M. J., Staatz, W. D., Nametz, N., Quigley, C., Campos, C. R., Brooks, T. A., & Davis, T. P. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05582.x · Cited by 71 · cited 1×
“Injection of λ-carrageenan into the plantat hindpaw could cause peripheral inflammatory pain, resulting in the increase of BBB permeability, promoted by the disruption of occludin oligomeric assemblies [56].”
BackgroundNatah, S. S., Srinivasan, S., Pittman, Q. J., Zhao, Z., & Dunn, J. F. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91484.2008 · Cited by 68
Lu, R., Wang, W., Uzzau, S., Vigorito, R., Zielke, H. R., & Fasano, A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740320.x · Cited by 66
Altered expression of claudin family proteins in Alzheimer's disease and vascular dementia brains
Romanitan, M. O., Popescu, B. O., Spulber, Å., BaÌjenaru, O., Popescu, L. M., Winblad, B., & Bogdanovic, N. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00999.x · Cited by 61
The Blood-Brain Barrier— Lessons from Moody Flies
Daneman, R., & Barres, B. A. (2005) · Cell · doi:10.1016/j.cell.2005.09.017 · Cited by 58
The Impact of ΔG on the Oral Bioavailability of Low Bioavailable Therapeutic Agents
Salama, N. N., Fasano, A., Thakar, M., & Eddington, N. D. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.073205 · Cited by 50
Sandoval, K. E., & WITT, K. A. (2010) · Microvascular Research · doi:10.1016/j.mvr.2010.12.007 · Cited by 49
Pu, H., Hayashi, K., Andras, I. E., Eum, S. Y., Hennig, B., & Toborek, M. J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.063 · Cited by 48
Ding, G., Qiu, L.-B., Wang, X.-W., Li, K., Zhou, Y., Zhou, Y., Zhang, J., Zhou, J.-X., Li, Y., & Guo, G. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.04.011 · Cited by 46
Sadowska, G. B., Malaeb, S. N., & Stonestreet, B. S. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00828.2009 · Cited by 44
Shin, K., & Margolis, B. L. (2006) · Cell · doi:10.1016/j.cell.2006.08.005 · Cited by 44
Silva, A. P., Martins, T., Baptista, S., Gonçalves, J., Agasse, F., & Malva, J. O. (2010) · Current Drug Abuse Reviews · doi:10.2174/1874473711003040239 · Cited by 43
Disruption of the blood–brain barrier in collagen-induced arthritic mice
Nishioku, T., Yamauchi, A., Takata, F., Watanabe, T., Furusho, K., Shuto, H., Dohgu, S., & Kataoka, Y. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.07.035 · Cited by 41
Paschoud, S., & Citi, S. (2007) · Molecular Membrane Biology · doi:10.1080/09687680701474009 · Cited by 41
HIV-1-Induced Alterations of Claudin-5 Expression at the Blood–Brain Barrier Level
András, I. E., & Toborek, M. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61779-185-7_26 · Cited by 41
Guo, J., Liu, A., & Su, D. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.141 · Cited by 40
Fan, L., Liu, Y., Ying, H., Xue, Y., Zhang, Z., Wang, P., Liu, L., & Zhang, H. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9479-x · Cited by 33
Enhancement of brain distribution of anticancer agents using ΔG, the 12kDa active fragment of ZOT
Menon, D., Karyekar, C. S., Fasano, A., Lu, R., & Eddington, N. D. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.09.006 · Cited by 27
Sellner, J., Weber, M. S., Vollmar, P., Mattle, H. P., Hemmer, B., & Stüve, O. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00179.x · Cited by 26
Sharma, H. S., Patnaik, R., & Sharma, A. (2010) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2010.3616 · Cited by 26
Jeliazkova-Mecheva, V. V., Hymer, W. C., Nicholas, N. C., & Bobilya, D. J. (2006) · Microvascular Research · doi:10.1016/j.mvr.2005.11.009 · Cited by 15
Cited by
Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies
Bowman, R. L., Klemm, F., Akkari, L., Pyonteck, S. M., Sevenich, L., Quail, D. F., Dhara, S., Simpson, K., Gardner, E. E., Iacobuzio-Donahue, C. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.052 · Cited by 619
Sevenich, L., Bowman, R. L., Mason, S. D., Quail, D. F., Rapaport, F., Elie, B. T., Brogi, E., Brastianos, P. K., Hahn, W. C., Holsinger, L. J., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3011 · Cited by 382
The Molecular Constituents of the Blood–Brain Barrier
Chow, B. W., & Gu, C. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.003 · Cited by 380
Marchetti, L., & Engelhardt, B. (2020) · Vascular Biology · doi:10.1530/vb-19-0033 · Cited by 304
Frontiers in the treatment of glioblastoma: Past, present and emerging
Janjua, T. I., Rewatkar, P., Ahmed-Cox, A., Saeed, I., Mansfeld, F. M., Kulshreshtha, R., Kumeria, T., Ziegler, D. S., Kavallaris, M., Mazzieri, R., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.012 · Cited by 257
Metadata
- Authors
- Liu, W., Wang, Z., Zhang, L., Wei, X., & Li, L.
- Venue
- CNS Neuroscience & Therapeutics
- Publisher
- Wiley
- Published
- 2012-06-12
- Volume
- 18
- Issue
- 8
- Pages
- 609-615
- ISSN
- 1755-5930 (ISSN-L)
- 1755-5949
- OpenAlex
- W1594197304
- Cited by
- 259
- References
- 103
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.